Company Executives

Amended and Restated Collaboration and Commercialization Agreement with Ascensia, which amended and restated the 2020 Commercialization Agreement and terminated Ascensia's U.S. marketing rights for Eversense

Master asset purchase agreement under which the Company acquired Ascensia's assets related to Eversense marketing and distribution in the United States, effective January 1, 2026

Net revenue from the Company's distribution arrangement with Ascensia as a share of total net revenues

Commissions due from the Company to Ascensia at year end

Amount due from Ascensia to the Company at year end

Purchases of medical supplies from Ascensia for clinical trials